Hypoglycaemia and counterregulation during childhood

Related Experiment Video

Updated: Oct 1, 2026

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice
07:35

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

K Matyka1, M Ford-Adams, D B Dunger

  • 1Department of Child Health, Birmingham Heartlands Hospital, UK.

Hormone Research
|April 30, 2002
PubMed

Insights

Counterregulatory responses to hypoglycemia are blunted in young children with type 1 diabetes, especially during sleep. Further research is needed to understand nocturnal hypoglycemia

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Diabetes Mellitus Research

Background:

  • Hypoglycemia is common in children with type 1 diabetes mellitus (T1DM).
  • Counterregulatory responses to hypoglycemia in this age group are poorly understood, with conflicting study results.
  • Nocturnal hypoglycemia's impact on neurocognitive function and cardiac health in T1DM requires further investigation.

Purpose of the Study:

  • To investigate counterregulatory hormone responses during nocturnal hypoglycemia in young children with T1DM.
  • To evaluate the contribution of nocturnal hypoglycemia to neurocognitive impairments in pediatric T1DM.
  • To explore the link between nocturnal hypoglycemia and adverse cardiac events in adolescents and young adults with T1DM.

Main Methods:

  • Review of existing studies on counterregulatory responses during spontaneous and induced hypoglycemia.
  • Analysis of neurocognitive performance in children with early-onset T1DM and history of severe hypoglycemia.
  • Examination of data linking nocturnal hypoglycemia to cardiac arrhythmia and sudden death in young T1DM patients.

Main Results:

  • Counterregulatory hormone responses appear blunted during nocturnal hypoglycemia, potentially due to sleep.
  • Cognitive deficits are consistently observed in T1DM children, particularly those with early onset or prior severe hypoglycemia.
  • Nocturnal hypoglycemia is associated with cardiac arrhythmia and sudden death risk in adolescents and young adults.

Conclusions:

  • Nocturnal hypoglycemia poses significant risks in young individuals with type 1 diabetes, including blunted responses and potential cognitive and cardiac issues.
  • New technologies like continuous glucose monitoring may facilitate better understanding and management of hypoglycemia in children.
  • Intensified insulin therapy with new analogues or CSII could improve care and compliance if hypoglycemia risks are mitigated.

More Related Videos

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

Published on: January 7, 2018

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...